Those infected with COVID-19 can now report potentially infected people
10.9.2021 13:45:29 EEST | HUS | Press release
A text message is sent to anyone who has received a positive COVID-19 test result. The message includes instructions to report any exposed persons in the MyCovidData.fi service. The service is used in the HUS area in all municipalities except Helsinki. Helsinki has its own system for reporting exposures.
‘The information provided in the service is useful preliminary information for infection tracers and speeds up the traceability process. The service can be used to report any locations the infected person has visited, and to write the names and telephone numbers of the people who have been exposed, as well as any other information related to the exposure’, says Deputy Chief Physician Eeva Ruotsalainen.
When the data is registered before an infection tracer calls, the data can be reviewed together and supplemented as necessary. The infection tracer confirms the exposures.
Using the service requires strong identification with online banking credentials or a mobile certificate. It is also possible to use the service on behalf of another person.
The service is now available in Finnish. Swedish and English versions of the service will soon be opened. In addition to municipalities in the HUS area, the service can be introduced in the areas of Kymote, Eksote and Northern Ostrobothnia Hospital Districts.
The address of the service is MyCovidData.fi.
Keywords
About HUS
At HUS Helsinki University Hospital about 680 000 patients receive medical care annually. We have almost 27,000 professionals working for the best of all patients. We are responsible for providing specialized health care for the residents of our 24 member municipalities. In addition, the treatment of many rare and severe diseases is nationally centralized to HUS.
HUS is the biggest health care provider and the second largest employer in Finland. Our expertise is internationally recognized and accredited. As a university hospital, we continuously develop and evaluate our treatment methods and activities.
Subscribe to releases from HUS
Subscribe to all the latest releases from HUS by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from HUS
Arbetet för babyvänlig verksamhet fortsätter – utvecklingsarbetet fortsätter med ny sammansättning2.7.2026 10:28:59 EEST | Pressmeddelande
Efter att Institutet för hälsa och välfärd THL:s nationella samordnande upphörde fortsätter arbetet för babyvänlig verksamhet i samarbete med alla välfärdsområden. Målet för den sakkunniggrupp som HUS har sammankallat är att trygga och utveckla babyvänlig vård i hela landet.
Vauvamyönteinen työ jatkuu – kehittämistyö jatkuu uudella kokoonpanolla2.7.2026 10:28:59 EEST | Tiedote
THL:n kansallisen koordinaation päätyttyä vauvamyönteisyystyö jatkuu yhteistyössä kaikkien hyvinvointialueiden kanssa. HUSin koollekutsuman asiantuntijaryhmän tavoitteena on turvata ja kehittää vauvamyönteistä hoitoa koko maassa.
Blodprov underlättar diagnostiken av lymfkörtelinflammationer i halsområdet hos barn1.7.2026 08:54:42 EEST | Pressmeddelande
En studie som genomförts vid HUS har bekräftat tillförlitligheten hos en blodprovsbaserad diagnostisk metod för lymfkörtelinflammationer i halsområdet hos barn som orsakas av miljömykobakterier. Ett blodprov är ett snabbare och för patienten mer skonsamt sätt att säkerställa diagnosen än invasiva metoder, såsom vävnadsprovtagning.
Verikoe helpottaa lasten kaulan alueen imusolmuketulehdusten diagnostiikkaa1.7.2026 08:54:42 EEST | Tiedote
HUSissa tehdyssä tutkimuksessa todennettiin verikokeeseen perustuvan diagnostisen menetelmän luotettavuus ympäristömykobakteerien aiheuttamissa lasten kaulan alueen imusolmuketulehduksissa. Verikoe on nopeampi ja potilaalle miellyttävämpi tapa varmistaa diagnoosi kuin kajoavat menetelmät, kuten koepalan otto.
A blood test aids the diagnosis of cervical lymphadenitis in children1.7.2026 08:54:42 EEST | Press release
A study conducted at HUS confirmed the reliability of a blood test-based method for diagnosing cervical lymphadenitis caused by nontuberculous mycobacteria (NTM) in children. A blood test is a faster and more comfortable way to confirm a diagnosis than invasive procedures, such as a biopsy.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom